Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
1
25%
Ph early_phase_1
1
25%
Ph phase_1
2
50%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(3)
Other(1)

Detailed Status

Withdrawn3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)
Phase 12 (50.0%)
N/A1 (25.0%)

Trials by Status

unknown125%
withdrawn375%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnearly_phase_1

Use of Adipose-Derived Stem/Stromal Cells in Concussion and Traumatic Brain Injuries

NCT02959294
withdrawnphase_1

Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions

NCT02939859
withdrawnphase_1

Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy

NCT02961114
unknownnot_applicable

Autologous Stem/Stromal Cells in Neurological Disorders and Disease

NCT03297177

Clinical Trials (4)

Showing 4 of 4 trials
NCT02959294Early Phase 1

Use of Adipose-Derived Stem/Stromal Cells in Concussion and Traumatic Brain Injuries

Withdrawn
NCT02939859Phase 1

Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions

Withdrawn
NCT02961114Phase 1

Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy

Withdrawn
NCT03297177Not Applicable

Autologous Stem/Stromal Cells in Neurological Disorders and Disease

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4